User:Mr. Ibrahem/Sunitinib

Sunitinib, sold under the brand name Sutent, is a medication used to treat cancer, specifically renal cell carcinoma (RCC), gastrointestinal stromal tumor (GIST), and pancreatic neuroendocrine tumor (pNET). It is taken by mouth.

Common side effects include tiredness, fever, nausea, diarrhea, inflammation of the mouth, abdominal pain, swelling, rash, pain, bleeding, and shortness of breath. Other side effects may include liver problems, osteonecrosis of the jaw, and prolonged QT. Use during pregnancy may harm the baby. It is a receptor tyrosine kinase (RTK) inhibitor.

Sunitinib was approved for medical use in the United States and Europe in 2006. In the United Kingdom 4 weeks of medication costs the NHS about £3,100 as of 2021. In the United States this amount costs about 4,900 USD.